Nanobiotix S.A.
NBTX
$3.39
$0.24117.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.04% | -116.03% | 0.85% | -90.11% | 1.09% |
| Total Depreciation and Amortization | -3.04% | 8.53% | -0.85% | 2.65% | -1.07% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -3.04% | 909.66% | -0.85% | -73.42% | -1.09% |
| Change in Net Operating Assets | -3.04% | -83.03% | -0.85% | 191.21% | -1.09% |
| Cash from Operations | 3.04% | -140.04% | 0.85% | -222.62% | -1.09% |
| Capital Expenditure | 3.01% | 25.46% | 0.83% | -9,729.63% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.15% | -813.56% | 1.67% | 34.78% | 1.08% |
| Cash from Investing | 3.04% | 7.06% | 0.85% | -2,200.00% | 1.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -3.08% | 0.00% | -8.71% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 39.08% | 0.00% | 93.50% | 0.00% |
| Cash from Financing | 3.04% | 4.59% | 0.85% | -105.47% | -1.09% |
| Foreign Exchange rate Adjustments | -2.86% | 21.21% | -0.86% | 230.90% | 1.11% |
| Miscellaneous Cash Flow Adjustments | -16.67% | -- | -- | -- | 0.00% |
| Net Change in Cash | 3.04% | -89.47% | 0.85% | -116.82% | -1.09% |